VOYA Investment Management’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $466K | Buy |
92,042
+25,352
| +38% | +$128K | ﹤0.01% | 1935 |
|
|
2025
Q1 | $353K | Sell |
66,690
-8,030
| -11% | -$42.5K | ﹤0.01% | 2035 |
|
|
2024
Q4 | $505K | Sell |
74,720
-392
| -0.5% | -$2.65K | ﹤0.01% | 1930 |
|
|
2024
Q3 | $495K | Buy |
75,112
+6,421
| +9% | +$42.3K | ﹤0.01% | 2002 |
|
|
2024
Q2 | $515K | Sell |
68,691
-57,601
| -46% | -$432K | ﹤0.01% | 1987 |
|
|
2024
Q1 | $1.26M | Buy |
126,292
+44,550
| +55% | +$444K | ﹤0.01% | 1531 |
|
|
2023
Q4 | $806K | Sell |
81,742
-554
| -0.7% | -$5.46K | ﹤0.01% | 1804 |
|
|
2023
Q3 | $630K | Buy |
82,296
+27,615
| +51% | +$211K | ﹤0.01% | 1914 |
|
|
2023
Q2 | $408K | Buy |
54,681
+2,076
| +4% | +$15.5K | ﹤0.01% | 2200 |
|
|
2023
Q1 | $351K | Hold |
52,605
| – | – | ﹤0.01% | 2243 |
|
|
2022
Q4 | $406K | Hold |
52,605
| – | – | ﹤0.01% | 2147 |
|
|
2022
Q3 | $560K | Buy |
52,605
+1,325
| +3% | +$14.1K | ﹤0.01% | 1958 |
|
|
2022
Q2 | $417K | Buy |
+51,280
| New | +$417K | ﹤0.01% | 1955 |
|
|
2022
Q1 | – | Sell |
-42,851
| Closed | -$734K | – | 2738 |
|
|
2021
Q4 | $734K | Buy |
42,851
+31,591
| +281% | +$541K | ﹤0.01% | 1755 |
|
|
2021
Q3 | $259K | Buy |
11,260
+3,089
| +38% | +$71.1K | ﹤0.01% | 2420 |
|
|
2021
Q2 | $298K | Buy |
+8,171
| New | +$298K | ﹤0.01% | 2381 |
|